Your browser doesn't support javascript.
loading
Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients.
Xiong, Yong; Liu, Yuan; Cao, Liu; Wang, Dehe; Guo, Ming; Jiang, Ao; Guo, Dong; Hu, Wenjia; Yang, Jiayi; Tang, Zhidong; Wu, Honglong; Lin, Yongquan; Zhang, Meiyuan; Zhang, Qi; Shi, Mang; Liu, Yingle; Zhou, Yu; Lan, Ke; Chen, Yu.
Afiliação
  • Xiong Y; State Key Laboratory of Virology, Department of Infectious Disease, Zhongnan Hospital, Wuhan University, Wuhan, People's Republic of China.
  • Liu Y; State Key Laboratory of Virology, Modern Virology Research Center, College of Life Sciences, Wuhan University, Wuhan, People's Republic of China.
  • Cao L; The Centre for Infection and Immunity Studies, School of Medicine, Sun Yat-sen University, Guangzhou, People's Republic of China.
  • Wang D; State Key Laboratory of Virology, Modern Virology Research Center, College of Life Sciences, Wuhan University, Wuhan, People's Republic of China.
  • Guo M; State Key Laboratory of Virology, Modern Virology Research Center, College of Life Sciences, Wuhan University, Wuhan, People's Republic of China.
  • Jiang A; State Key Laboratory of Virology, Modern Virology Research Center, College of Life Sciences, Wuhan University, Wuhan, People's Republic of China.
  • Guo D; State Key Laboratory of Virology, Modern Virology Research Center, College of Life Sciences, Wuhan University, Wuhan, People's Republic of China.
  • Hu W; State Key Laboratory of Virology, Department of Infectious Disease, Zhongnan Hospital, Wuhan University, Wuhan, People's Republic of China.
  • Yang J; State Key Laboratory of Virology, Modern Virology Research Center, College of Life Sciences, Wuhan University, Wuhan, People's Republic of China.
  • Tang Z; State Key Laboratory of Virology, Modern Virology Research Center, College of Life Sciences, Wuhan University, Wuhan, People's Republic of China.
  • Wu H; BGI PathoGenesis Pharmaceutical Technology, Shenzhen, People's Republic of China.
  • Lin Y; BGI PathoGenesis Pharmaceutical Technology, Shenzhen, People's Republic of China.
  • Zhang M; BGI PathoGenesis Pharmaceutical Technology, Shenzhen, People's Republic of China.
  • Zhang Q; State Key Laboratory of Virology, Modern Virology Research Center, College of Life Sciences, Wuhan University, Wuhan, People's Republic of China.
  • Shi M; The Centre for Infection and Immunity Studies, School of Medicine, Sun Yat-sen University, Guangzhou, People's Republic of China.
  • Liu Y; State Key Laboratory of Virology, Modern Virology Research Center, College of Life Sciences, Wuhan University, Wuhan, People's Republic of China.
  • Zhou Y; State Key Laboratory of Virology, Modern Virology Research Center, College of Life Sciences, Wuhan University, Wuhan, People's Republic of China.
  • Lan K; State Key Laboratory of Virology, Modern Virology Research Center, College of Life Sciences, Wuhan University, Wuhan, People's Republic of China.
  • Chen Y; State Key Laboratory of Virology, Modern Virology Research Center, College of Life Sciences, Wuhan University, Wuhan, People's Republic of China.
Emerg Microbes Infect ; 9(1): 761-770, 2020 Dec.
Article em En | MEDLINE | ID: mdl-32228226
Circulating in China and 158 other countries and areas, the ongoing COVID-19 outbreak has caused devastating mortality and posed a great threat to public health. However, efforts to identify effectively supportive therapeutic drugs and treatments has been hampered by our limited understanding of host immune response for this fatal disease. To characterize the transcriptional signatures of host inflammatory response to SARS-CoV-2 (HCoV-19) infection, we carried out transcriptome sequencing of the RNAs isolated from the bronchoalveolar lavage fluid (BALF) and peripheral blood mononuclear cells (PBMC) specimens of COVID-19 patients. Our results reveal distinct host inflammatory cytokine profiles to SARS-CoV-2 infection in patients, and highlight the association between COVID-19 pathogenesis and excessive cytokine release such as CCL2/MCP-1, CXCL10/IP-10, CCL3/MIP-1A, and CCL4/MIP1B. Furthermore, SARS-CoV-2 induced activation of apoptosis and P53 signalling pathway in lymphocytes may be the cause of patients' lymphopenia. The transcriptome dataset of COVID-19 patients would be a valuable resource for clinical guidance on anti-inflammatory medication and understanding the molecular mechansims of host response.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pneumonia Viral / Líquido da Lavagem Broncoalveolar / Leucócitos Mononucleares / Citocinas / Infecções por Coronavirus / Quimiocinas / Transcriptoma Tipo de estudo: Guideline / Prognostic_studies Limite: Humans Idioma: En Revista: Emerg Microbes Infect Ano de publicação: 2020 Tipo de documento: Article País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pneumonia Viral / Líquido da Lavagem Broncoalveolar / Leucócitos Mononucleares / Citocinas / Infecções por Coronavirus / Quimiocinas / Transcriptoma Tipo de estudo: Guideline / Prognostic_studies Limite: Humans Idioma: En Revista: Emerg Microbes Infect Ano de publicação: 2020 Tipo de documento: Article País de publicação: Estados Unidos